Extension of Warrant Exercise Date

Asimilar

31/03/2021 18:04

RNS Number : 2066U

Asimilar Group PLC

31 March 2021

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

 

31 March 2021

 

 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

 

Extension of Warrant Exercise Deadline

 

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), announces that it has extended the expiry date in relation to the 11,562,500 warrants issued by the Company with an exercise price of 30p per share in conjunction with a placing announced on 18 December 2019 ("Warrants").  As at the time of this announcement, 3,750,000 Warrants have already been exercised. 

 

The Company has agreed to extend the final exercise date of the Warrants from 5pm on 31 March 2021 to 5pm on 9 April 2021.  The extension has been agreed by the relevant warrant holders and the Company pursuant to the terms of the warrant instrument.

 

 

 

-ends-

 

 

For further information please contact:

Asimilar Group plc
John Taylor, Non-Executive Chairman
via Buchanan
Cairn Financial Advisers LLP
Sandy Jamieson / Liam Murray
Tel: +44 20 7213 0880
Peterhouse Capital Limited
Duncan Vasey / Lucy Williams
Tel: + 44 20 7220 9797
Buchanan Communications Limited
Richard Oldworth / Chris Lane
Tel: +44 (0) 20 7466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
MSCDKDBKOBKDBNN